In addition, we defined the level of CARM1 expression according to the immunohistochemical score of CARM1 and found that the expression of CARM1 was significantly negatively correlated with lipid ROS and MDA levels in CRC tumor tissues of patients (Figure 1h–k). This evidence concerns the gene CARM1 and colorectal carcinoma.